Matinas BioPharma | Investor Presentation Deck | 29 slides · page 12 of 29
Focuses on clinical success in a compassionate use setting.
Pitch deck · traction · show_traction · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
callout 1/1 list 6/6 title 1/1
Components 8
primary bullet bullet bullet bullet bullet bullet headline
Tools 2
Audience Definition slide · 70%
14 patients with no other treatment options are currently receiving or have completed treatment with MAT2203. Notable Healthcare Institutions: NIH, University of Michigan, Johns Hopkins, City of Hope, Nation
Story Moments slide · 60%All patients who received at least two weeks or more of treatment had positive clinical outcomes with significant success stories of full recovery in majority of patients.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.